Showing 941-950 of 3315 results for "".
New Myopia Software on Pentacam AXL
https://modernod.com/podcasts/eyewire-news-the-podcast/new-myopia-software-on-pentacam-axl/37073/Oculus launches new myopia software on its Pentacam AXL; the first clinical polygenic risk score test for glaucoma in the US is launched; and Virtual Vision Health releases visual acuity testing on its VR platform Learn more about your ad choices. Visit megaphone.fm/adchoicesFDA Approves Genentech's Susvimo Ocular Implant for DME
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-genentechs-susvimo-ocular-implant-for-dme/37070/The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its C.Rex micro-interventional system; and there are several executive leadership announcements made in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesPhase 3 Results for Novel Sedation Tablet
https://modernod.com/podcasts/eyewire-news-the-podcast/phase-3-results-for-novel-sedation-tablet/37062/New phase 3 data is released for a non-opioid sedation tablet; the first patient is dosed in the phase 3 trial of EyePoint’s wet AMD candidate; and Outlook receives a reimbursement decision in the UK for its wet AMD treatment. Learn more about your ad choices. Visit megaphone.fm/adchoicesMeibomian Gland Probing
https://modernod.com/podcasts/to-the-point/meibomian-gland-probing/36941/This month on To the Point, learn about meibomian gland probing in patients with dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. Their guest, Rana Taji, OD, MSc, FAAO, explains what it is, how to do it, why to do it, and more.Phakic IOL for Presbyopia Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/phakic-iol-for-presbyopia-approved-in-europe/37061/A new phakic IOL for presbyopia is approved in Europe; Nidek launches its preloaded Toric IOL Injection System internationally; and the FDA cleared a novel device for the treatment of Meibomian Gland Dysfunction. Learn more about your ad choices. Visit megaphone.fm/adchoicesLLLT and AMD: Your Questions Answered
https://modernod.com/topics/retina/lllt-and-amd-your-questions-answered/37350/Joseph J. Allen, OD, FAAO, Dipl ABO, gives an overview of a recently FDA-authorized low-level light therapy, or photobiomodulation, device, the Valeda Light Delivery System (LumiThera). He explains the device’s unique mechanism of action for treating age-related macular degeneration, reviews promisiOcular Surface Squamous Neoplasia in an Avid Sailor With Poor Compliance to Sun Protective Measures
https://modernod.com/mod-issues/novemberdecember-2024-supplement/ocular-surface-squamous-neoplasia-in-an-avid-sailor-with-poor-compliance-to-sun-protective-measures/38886/Ophthalmic Executives Provide Company Updates (Part 2 of 2)
https://modernod.com/podcasts/eyewire-news-the-podcast/ophthalmic-executives-provide-company-updates-part-2-of-2/37058/Leaders of several ophthalmic companies with a focus on the posterior segment provide updates on their pipeline and new products in this special edition of EyewireTV.Females on the Forefront of Optometry
https://modernod.com/topics/human-interest/females-on-the-forefront-of-optometry/38853/Insights from three prominent women in the profession who have helped pave the way for future leaders.LLLT: Not Just for Dry Eye
https://modernod.com/videos/eye-care-insiders/lllt-not-just-for-dry-eye/37347/Joseph J. Allen, OD, FAAO, Dipl ABO, discusses low-level light therapy (LLLT), which has been used in the treatment of dry eye, as a potential use for the management of myopia. He explains how LLLT, aka red light therapy, works to achieve a therapeutic benefit through photobiomodulation, provides a